Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014:2014:360970.
doi: 10.1155/2014/360970. Epub 2014 Dec 21.

Mucocutaneous Manifestations of HIV and the Correlation with WHO Clinical Staging in a Tertiary Hospital in Nigeria

Affiliations

Mucocutaneous Manifestations of HIV and the Correlation with WHO Clinical Staging in a Tertiary Hospital in Nigeria

Olumayowa Abimbola Oninla. AIDS Res Treat. 2014.

Abstract

Skin diseases are indicators of HIV/AIDS which correlates with WHO clinical stages. In resource limited environment where CD4 count is not readily available, they can be used in assessing HIV patients. The study aims to determine the mucocutaneous manifestations in HIV positive patients and their correlation with WHO clinical stages. A prospective cross-sectional study of mucocutaneous conditions was done among 215 newly diagnosed HIV patients from June 2008 to May 2012 at adult ART clinic, Wesley Guild Hospital Unit, OAU Teaching Hospitals Complex, Ilesha, Osun State, Nigeria. There were 156 dermatoses with oral/oesophageal/vaginal candidiasis (41.1%), PPE (24.4%), dermatophytic infections (8.9%), and herpes zoster (3.8%) as the most common dermatoses. The proportions of dermatoses were 4.5%, 21.8%, 53.2%, and 20.5% in stages 1-4, respectively. A significant relationship (using Pearson's Chi square with P value <0.05) was obtained between dermatoses and WHO clinical stages. Pearson's correlation coefficient showed a positive correlation between the number of dermatoses and the WHO clinical stages. Dermatoses can therefore serve as diagnostic and prognostic markers in resource limited settings to initiate HAART in clinical stages 3 and 4.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Kingman S. Growing awareness of skin disease starts flurry of initiatives. Bulletin of the World Health Organization. 2005;83:891–892. - PMC - PubMed
    1. Satimia F. T., McBride S. R., Leppard B. Prevalence of skin disease in rural Tanzania and factors influencing the choice of health care, modern or traditional. Archives of Dermatology. 1998;134(11):1363–1366. - PubMed
    1. Porter M. J. Problems and priorities for dermatology in developing countries. International Journal of Dermatology. 1978;12:233–236. - PubMed
    1. Hay R. J., Steer A. C., Engelman D., et al. Scabies in the developing world—its prevalence, complications, and management. Clinical Microbiology and Infection. 2012;18(4):131–323. doi: 10.1111/j.1469-0691.2012.03798.x. - DOI - PubMed
    1. Oninla O. A., Onayemi O. Skin infections and infestations in prison inmates. International Journal of Dermatology. 2012;51(2):178–181. doi: 10.1111/j.1365-4632.2011.05016.x. - DOI - PubMed

LinkOut - more resources